Navigation Links
Total Artificial Heart Patient Enjoys Spotlight as "The Only Man in Turkey Who Lives Without a Heart"
Date:9/29/2011

TUCSON, Ariz., Sept. 29, 2011 /PRNewswire/ -- In May 2011, Omer Bayrak made headlines when he became the first patient in Turkey to be discharged from the hospital using the Freedom® portable driver to power his SynCardia temporary Total Artificial Heart. Since returning home to wait for a matching donor heart, Mr. Bayrak has been enjoying his new-found celebrity as "the only man in Turkey who lives without a heart."

(Photo: http://photos.prnewswire.com/prnh/20110929/LA77026-a)

(Photo: http://photos.prnewswire.com/prnh/20110929/LA77026-b)

(Photo: http://photos.prnewswire.com/prnh/20110929/LA77026-c)

On Sept. 17, after almost 180 days of support with SynCardia's Total Artificial Heart, Mr. Bayrak attended the annual meeting of the Turkish Society for Artificial Organs and Support Systems (TUYOD). During a session about the Total Artificial Heart, he was invited to the stage and the audience asked him several questions. He responded that he was "doing really well and very comfortable with SynCardia's Total Artificial Heart." He also added that he is continuing his daily life with very few limitations, and has returned to work.

Mr. Bayrak is also currently featured on an eight-story tall billboard on Florence Nightingale Hospital in Istanbul. In English, the billboard reads, "The only man in Turkey who lives without a heart but with an artificial heart. Florence Nightingale Heart Transplant and Total Artificial Heart Center."

Prior to receiving SynCardia's Total Artificial Heart, Mr. Bayrak had been suffering from congestive heart failure since 2001. Four years ago, he underwent cardiac resynchronization therapy and received an implantable cardioverter-defibrillator (ICD). Last year, he was hospitalized 11 times for inotropic support.

For 15 days prior to receiving SynCardia's Total Artificial Heart, Mr. Bayrak had been in the cardiac intensive care unit. He was on the urgent list for heart transplantation but his cardiac function continued to worsen. As a result, on March 21, 2011, he became the hospital's first patient to receive SynCardia's Total Artificial Heart.

Three months later, on May 20, 2011, Mr. Bayrak was discharged from the hospital to wait for a matching donor heart at home using the Freedom portable driver, the world's first wearable power supply for SynCardia's Total Artificial Heart. The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

SynCardia recognizes and thanks Ufuk Yaranli and Natura Medikal Urunler Ltd., the Turkish distributor for the Total Artificial Heart, for their commitment and on-going support of Florence Nightingale Hospital.

CAUTION – The Freedom® portable driver is an investigational device, limited by United States law to investigational use.

About the SynCardia temporary Total Artificial Heart

SynCardia Systems, Inc. (Tucson, AZ) is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. Originally used as a permanent replacement heart, the Total is currently approved as a bridge to transplant for people dying from end-stage biventricular heart failure. More than 950 implants account for more than 230 patient years of life.

Similar to a heart transplant, SynCardia's Total Artificial Heart replaces both failing heart ventricles and the four heart valves. It is the only device that eliminates the symptoms and source of end-stage biventricular failure. The Total Artificial Heart provides immediate, safe blood flow of up to 9.5 liters per minute through both ventricles. This high volume of safe blood flow helps speed the recovery of vital organs, helping make the patient a better transplant candidate.

In March 2011, Fast Company magazine ranked SynCardia #20 among the World's 50 Most Innovative Companies "for giving mobility to artificial heart recipients." Also in March, the longest running health and wellness series on public television, "Healthy Body, Healthy Mind," produced a 30-minute program featuring SynCardia's Total Artificial Heart. View here

For additional information, please visit: http://www.syncardia.com
Like SynCardia on Facebook
Follow SynCardia on Twitter – @SynCardia
Connect with SynCardia on LinkedIn


'/>"/>
SOURCE SynCardia Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. 1st Pediatric Total Artificial Heart Patient Discharged Home Using Freedom® Portable Driver
2. University of Muenster Bridges 1st Patient to Transplant with SynCardias Total Artificial Heart
3. PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
4. Combined Sales of Seven Emerging Therapies for Breast Cancer, Including Drugs From Sanofi-Aventis and AstraZeneca, Will Total Nearly $5 Billion by 2019
5. Biostar Pharmaceuticals, Inc. Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500
6. SCARGUARD LABS, LLC Announces Key Consumption Results Fastest Growing Brand and Second in Total Rankings
7. Healthcare Network Helps Fund Scholarships Totaling $15,000
8. ASP Sterrad Technology Approved by AFSSAPS for Total Inactivation of Prions
9. Robert Zanotti, MD, Is First Lorain County, Ohio Orthopedic Surgeon to Perform Reverse Total Shoulder Replacement
10. ALPCO Introduces a Mouse HMW and Total Adiponectin ELISA
11. NASA Extends Bioastronautics Contract With Wyle for Total Value of $976 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... , Feb. 22, 2017  PrimeVax Immuno-Oncology, Inc. ... be presenting at the Annual Biocom Global Life Science ... 2, at 11:15 AM, at the Torrey Pines Lodge, ... to the organizers at Biocom who have chosen our ... symposium of biotechnology companies, investors, and clinical researchers," said ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... provider of women’s health, primary care, and specialty education, announced today it ... Education (ACCME). ACCME’s Accreditation with Commendation is a six-year accreditation and is ...
(Date:2/22/2017)... (PRWEB) , ... February 22, 2017 , ... ... for tech innovators, engineers, and scientists from around the world, is pleased to ... on February 22 and 23, 2017. This premier, online-only conference focused on the ...
(Date:2/22/2017)... Dublin - Research and Markets has announced ... Type, By Application, By End User, By Region, By Country: Opportunities ... ... is forecasted to grow at a CAGR of 11.33% during 2016-2021. ... protection market is driven by the surging demand for less toxic ...
Breaking Biology Technology:
(Date:2/9/2017)... 2017 The biomass boiler market report by ... boiler market globally in terms of revenue (US$ Mn) ... market for biomass boilers has been segmented on the ... country/region. The market based on feedstock type, has been ... & energy crops, urban residues, and others. On the ...
(Date:2/8/2017)... , Feb. 7, 2017 Report Highlights ... The global synthetic-biology ... $11.4 billion by 2021, growing at a compound annual growth ... An overview of the global markets for synthetic biology. - ... for 2016, and projections of compound annual growth rates (CAGRs) ...
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
Breaking Biology News(10 mins):